4.6 Article

Development of LIBRA-seq for the guinea pig model system as a tool for the evaluation of antibody responses to multivalent HIV-1 vaccines

Related references

Note: Only part of the references are listed.
Article Cell Biology

Functional HIV-1/HCV cross-reactive antibodies isolated from a chronically co-infected donor

Kelsey A. Pilewski et al.

Summary: In a study of a chronically HIV-1/HCV co-infected individual, researchers identified five cross-reactive antibodies that show exceptional neutralization breadth and effector functions against both HIV-1 and HCV. One antibody also cross-reacts with influenza and coronaviruses, including SARS-CoV-2. The development of these antibodies is closely related to somatic hypermutation, providing potential directions for therapeutic and vaccine development against current and emerging infectious diseases. Chronic co-infection represents a complex immunological challenge that can provide insights into the fundamental rules of antibody-antigen specificity.

CELL REPORTS (2023)

Article Microbiology

Impact of stabilizing mutations on the antigenic profile and glycosylation of membrane-expressed HIV-1 envelope glycoprotein

Tommy Tong et al.

Summary: An effective vaccine to block HIV-1 infection remains elusive due to the difficulty in creating pure authentic envelope glycoprotein. Current vaccine research focuses on stabilizing soluble envelope trimers, but incomplete authenticity may limit efficacy. In this study, we evaluated the effects of stabilizing mutations on membrane-expressed envelope mRNA vaccines and found that some mutations alter the conformation and may not be suitable for nucleic acid-based vaccines.

PLOS PATHOGENS (2023)

Correction Immunology

Strategies for HIV-1 vaccines that induce broadly neutralizing antibodies(vol 23, pg 142, 2023)

Barton F. Haynes et al.

NATURE REVIEWS IMMUNOLOGY (2023)

Review Immunology

To bnAb or Not to bnAb: Defining Broadly Neutralising Antibodies Against HIV-1

Sarah A. Griffith et al.

Summary: Research on HIV-1 bnAbs has shown that an exact definition of what constitutes a bnAb has not been established, resulting in the study of a variety of antibodies with different neutralisation breadth, revealing insights into antibody maturation pathways and targeted epitopes, while current immunisation studies and vaccine trials have had limited success in producing bnAbs.

FRONTIERS IN IMMUNOLOGY (2021)

Article Virology

Elicitation of Neutralizing Antibody Responses to HIV-1 Immunization with Nanoparticle Vaccine Platforms

Amyn A. Murji et al.

Summary: Utilizing Env diversity in nanoparticle-based vaccine formulations has the potential to elicit broadly neutralizing antibody responses against HIV-1. The development of nanoparticle immunogens containing Envs from different strains can induce high antibody titers in both mice and guinea pigs. These results suggest promising strategies for incorporating Env sequence diversity in the development of broadly protective HIV-1 vaccines.

VIRUSES-BASEL (2021)

Review Biochemistry & Molecular Biology

The Conformational States of the HIV-1 Envelope Glycoproteins

Qian Wang et al.

TRENDS IN MICROBIOLOGY (2020)

Article Microbiology

Antigen-Specific Single B Cell Sorting and Monoclonal Antibody Cloning in Guinea Pigs

Lin Lei et al.

FRONTIERS IN MICROBIOLOGY (2019)

Article Biochemistry & Molecular Biology

High-Throughput Mapping of B Cell Receptor Sequences to Antigen Specificity

Ian Setliff et al.

Review Immunology

Polyvalent vaccine approaches to combat HIV-1 diversity

Bette Korber et al.

IMMUNOLOGICAL REVIEWS (2017)

Article Biochemistry & Molecular Biology

Cooperation of B Cell Lineages in Induction of HIV-1-Broadly Neutralizing Antibodies

Feng Gao et al.

Review Biochemical Research Methods

Optimization and validation of the TZM-bl assay for standardized assessments of neutralizing antibodies against HIV-1

Marcella Sarzotti-Kelsoe et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2014)

Article Multidisciplinary Sciences

Developmental pathway for potent V1V2-directed HIV-neutralizing antibodies

Nicole A. Doria-Rose et al.

NATURE (2014)

Article Multidisciplinary Sciences

Recombinant HIV envelope trimer selects for quaternary-dependent antibodies targeting the trimer apex

Devin Sok et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)

Article Multidisciplinary Sciences

Conformational dynamics of single HIV-1 envelope trimers on the surface of native virions

James B. Munro et al.

SCIENCE (2014)

Article Biochemistry & Molecular Biology

Supersite of immune vulnerability on the glycosylated face of HIV-1 envelope glycoprotein gp120

Leopold Kong et al.

NATURE STRUCTURAL & MOLECULAR BIOLOGY (2013)

Article Multidisciplinary Sciences

Immunoglobulin Genomics in the Guinea Pig (Cavia porcellus)

Yongchen Guo et al.

PLOS ONE (2012)

Article Biochemical Research Methods

A robust, high-throughput assay to determine the phagocytic activity of clinical antibody samples

Margaret E. Ackerman et al.

JOURNAL OF IMMUNOLOGICAL METHODS (2011)

Article Multidisciplinary Sciences

Broad neutralization coverage of HIV by multiple highly potent antibodies

Laura M. Walker et al.

NATURE (2011)

Article Multidisciplinary Sciences

Electron tomography analysis of envelope glycoprotein trimers on HIV and simian immunodeficiency virus virions

P Zhu et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)